Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.605
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.934
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.728
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.805
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.278
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.229
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.181
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0583
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.804
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.596
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.203
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.921
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
2.39×10-07
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.444
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
5.48×10-06
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 NKT cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.0852
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B1B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000154
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.183
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.863
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.781
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.854
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.752
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell volume
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00739
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Subset
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Transitional B Cells (CD21/35 low)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.690
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Organ Weight / Spleen weight
|
HET
|
5f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.280
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Organ Weight / Spleen weight
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.995
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN NKT cells
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.155
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.925
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.925
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.465
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0535
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.705
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Neutrophils
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.467
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Platelet count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.277
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.990
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Monocytes
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.250
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.833
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.133
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.390
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Follicular B Cells (CD21/35+)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.804
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.470
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / Eosinophils
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.285
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.444
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
8.37×10-06
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.352
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.675
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000226
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.703
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.565
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hemoglobin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.112
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.663
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.176
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.722
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.495
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.183
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / MZB (CD21/35 high)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.294
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / cDCs
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.752
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.650
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK cells (panel A)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
6f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.858
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B2B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DP T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Hematocrit
|
HET
|
14f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.00521
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD25- T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Red blood cell distribution width
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
9.64×10-05
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.315
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T Cells (panel B)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.410
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / pDCs
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.922
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
6f:5m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.444
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.00548
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / Mean platelet volume
|
HET
|
14f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.527
|
Successful |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / T cells (panel A)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / B Cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
2f:2m
|
|
|
NotProcessed |
Wars1tm1b(EUCOMM)Hmgu
|
HMGU
|
Hematology / White blood cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.188
|
Successful |